A detailed history of Geode Capital Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,474,632 shares of MXCT stock, worth $8.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,474,632
Previous 2,426,672 1.98%
Holding current value
$8.86 Million
Previous $9.51 Million 1.2%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.68 - $5.06 $176,492 - $242,677
47,960 Added 1.98%
2,474,632 $9.63 Million
Q2 2024

Aug 09, 2024

BUY
$3.63 - $5.0 $1.08 Million - $1.49 Million
298,358 Added 14.02%
2,426,672 $9.51 Million
Q1 2024

May 13, 2024

BUY
$3.94 - $5.38 $125,358 - $171,175
31,817 Added 1.52%
2,128,314 $8.92 Million
Q4 2023

Feb 13, 2024

BUY
$2.6 - $5.24 $319,956 - $644,834
123,060 Added 6.24%
2,096,497 $9.85 Million
Q3 2023

Nov 13, 2023

BUY
$3.02 - $5.1 $539,930 - $911,803
178,785 Added 9.96%
1,973,437 $6.16 Million
Q2 2023

Aug 11, 2023

BUY
$3.69 - $5.35 $425,368 - $616,726
115,276 Added 6.86%
1,794,652 $8.24 Million
Q1 2023

May 15, 2023

BUY
$4.03 - $5.89 $226,949 - $331,695
56,315 Added 3.47%
1,679,376 $8.31 Million
Q4 2022

Feb 13, 2023

BUY
$4.92 - $7.4 $240,760 - $362,119
48,935 Added 3.11%
1,623,061 $8.86 Million
Q3 2022

Nov 14, 2022

BUY
$4.52 - $6.51 $3.59 Million - $5.17 Million
794,469 Added 101.9%
1,574,126 $10.2 Million
Q2 2022

Aug 12, 2022

SELL
$3.59 - $6.81 $344,794 - $654,052
-96,043 Reduced 10.97%
779,657 $3.69 Million
Q1 2022

May 13, 2022

BUY
$5.26 - $10.84 $373,728 - $770,192
71,051 Added 8.83%
875,700 $6.12 Million
Q4 2021

Feb 11, 2022

BUY
$8.87 - $12.94 $5.86 Million - $8.55 Million
660,867 Added 459.63%
804,649 $8.2 Million
Q3 2021

Nov 12, 2021

BUY
$12.21 - $17.2 $1.76 Million - $2.47 Million
143,782 New
143,782 $1.76 Million

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $364M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.